Primary Pain Palliation and Local Tumor Control in Bone Metastases Treated With Magnetic Resonance-guided Focused Ultrasound
Unlike previous studies, in which patients were enrolled for MRgFUS treatment because of the
failure of other therapies, our study will be conducted in patients not previously treated
with EBRT to the targeted lesion.
This is an important new feature, especially given the advantages of MRgFUS, such as lack of
ionizing radiation, the ability to conduct treatment on an outpatient basis and the
possibility to repeat the treatment as necessary.
Interventional
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
To evaluate the safety and efficacy of Magnetic Resonance-guided Focused Ultrasound (MRgFUS) for the primary treatment of painful bone metastases
Patients will be monitored for major or minor adverse events
6 months
Yes
Alessandro Napoli, MD, PhD
Principal Investigator
Department of Radiological Sciences, Sapienza University of Rome
Italy: Ethics Committee
BM-MRgFUS
NCT01693770
January 2011
February 2013
Name | Location |
---|